Esophageal cancer microbiome and leak after surgery
Part of Cancer, Digestive system clinical trials.
This study looks at bacteria in esophageal cancer tumors and whether certain bacteria are linked to leaks that can happen after surgery to remove the esophagus. It may help doctors understand how to prevent these leaks in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer that has not spread to other parts of the body (non-metastatic).
- Your cancer is located in the middle of the esophagus or at the junction with the stomach (Siewert type 1 or 2).
- You have had surgery to remove the tumor (esophagectomy) at Rambam Hospital.
- You either developed a leak where the esophagus was reconnected after surgery, or you had no problems after surgery.
- You have given permission for your tissue sample to be stored and used for research (through Rambam BioBank or Midgam).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people having surgery to remove part of the esophagus (esophagectomy) who are at higher risk for a leak where the esophagus is reconnected. The goal is to learn more about who develops leaks and how to prevent them.
This study looks at the role of tiny organisms (the microbiome) in leaks from the esophagus or stomach. Researchers will take small tissue samples to learn more about these leaks and how to treat them better.
This study looks at infections that can happen after surgery to remove the esophagus (esophagectomy) for cancer. Understanding these infections may help doctors improve care after this procedure.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This trial looks at whether a personalized blood test can detect cancer returning after surgery for esophageal cancer. It tests people who had chemoradiotherapy before surgery and still had some cancer remaining in the removed tissue. The goal is to use the blood test to catch any remaining or returning cancer early.
This study tests a new way to manage complications after esophageal cancer surgery using a special algorithm. The goal is to improve recovery and care for patients who have this surgery.
Hear when a new Esophageal Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.